The Analysis of Fairmount Funds Management LLC's Holdings
Currently, Fairmount Funds Management LLC holds 18 types of securities in its portfolio with a total value $1.2B. In the most recent quarter, they have increased their positions in ABVX (+713.4K shares, valued at $60.6M), CBIO (+4.3M shares, valued at $50.6M), COGT (+2.8M shares, valued at $39.9M); initiated new positions in ABVX (+713.4K shares, valued at $60.6M), GLTO (+397.0K shares, valued at $6.9M). Stock Holdings
TickerCompany NameSharesShares âŗ%Event DateReport DateHistory
DNTH DIANTHUS THERAPEUTICS INC3.3M shares22.16%2025-09-302025-11-14
COGT COGENT BIOSCIENCES INC9.0M shares44.62%2025-09-302025-11-14 AXSM AXSOME THERAPEUTICS INC815.2K shares0.00%2025-09-302025-11-14 CBIO CRESCENT BIOPHARMA INC.5.6M shares306.63%2025-12-042025-12-08 APGE APOGEE THERAPEUTICS INC2.0M shares0.00%2025-09-302025-11-14 ELVN ENLIVEN THERAPEUTICS INC3.7M shares0.00%2025-09-302025-11-14 VRDN VIRIDIAN THERAPEUTICS INC3.5M shares0.00%2025-09-302025-11-14 ORKA ORUKA THERAPEUTICS INC3.7M shares9.89%2025-09-302025-11-14 KNSA KINIKSA PHARMACEUTICALS INTL1.8M shares0.00%2025-09-302025-11-14 SRRK SCHOLAR ROCK HLDG CORP1.8M shares0.00%2025-09-302025-11-14 SYRE SPYRE THERAPEUTICS INC4.0M shares0.00%2025-09-302025-11-14 NUVL NUVALENT INC727.6K shares0.00%2025-09-302025-11-14 ABVX ABIVAX SA713.4K sharesnew addition2025-09-302025-11-14 ZBIO ZENAS BIOPHARMA INC1.9M shares0.00%2025-09-302025-11-14 JBIO JADE BIOSCIENCES INC3.2M shares0.00%2025-09-302025-11-14 ATXS ASTRIA THERAPEUTICS INC3.6M shares0.00%2025-09-302025-11-14 IKT INHIBIKASE THERAPEUTICS INC6.1M shares0.00%2025-09-302025-11-14 GLTO 397.0K sharesnew addition2025-11-102025-11-17 Call Option Holdings
No call option holdings data available
Put Option Holdings
No put option holdings data available